Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

ction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs. For more information about Ampio, please visit our website, www.ampiopharma.com.

Forward-Looking Statements
Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, successful commercialization and marketing of Zertane™ and the combination drug in Korea, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Contact: Investor Relations, Ampio Pharmaceuticals, Inc., 720-437-6500


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014 SynCardia Systems, Inc., has been ... for Small Companies presented by the Arizona Technology Council ... The 11th annual Governor,s Celebration of Innovation Awards honor ... . Arizona Governor Jan ... SynCardia was honored for its Freedom® portable driver, which ...
(Date:11/18/2014)... , November 18, 2014 Profile Solutions, ... provider of access control and security systems is ... the Green Rush Alliance and will provide the ... businesses in the Cannabis Industry. The Company will ... medical marijuana dispensaries, retailers and grow operations. ...
(Date:11/18/2014)... 2014   Headquartered in Anaheim, California ... a diversified company.  WholeHEALTH Products Inc. is focused on ... and proven expertise of its team of professionals ... wellness.  WholeHEALTH Products, comprehensive line of 22 professional ... centers, and 8 retail consumer tests is your ...
Breaking Medicine Technology:SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3Profile Solutions, Inc Joins the Green Rush Alliance 2Profile Solutions, Inc Joins the Green Rush Alliance 3WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2
... 7 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" ... Chinese medicines ("TCM"), today announced,that, commencing on July 2, 2010 , ... symbol "CBP". , , , ... On this occasion, Mr. Shaoming Li , Chairman of ...
... July 7 Reportlinker.com announces that a new market research report is available ... Stakeholder Opinions: Vaccines in ... , , ... , , ...
Cached Medicine Technology:Renhuang Begins Trading on NYSE Amex 2Renhuang Begins Trading on NYSE Amex 3Renhuang Begins Trading on NYSE Amex 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 9Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 10Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 11Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 12Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 13Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 14
(Date:11/21/2014)... THURSDAY, Nov. 20, 2014 (HealthDay News) -- Kidney donation ... do for another. And now a new study finds that ... life are benefiting from policies that give them priority on ... almost 6,300 of the 16,900 kidney transplants that took place ... supplied by the study researchers. At the time ...
(Date:11/18/2014)... Cristcot Inc., a global life ... of specialized drug delivery systems, today announced that ... patent for the technology, which encompasses the company’s ... The patent was awarded to the inventor Jennifer ... assigned to Cristcot Inc. The patented technology, titled ...
(Date:11/18/2014)... TX (PRWEB) November 18, 2014 ... advice and insights, adding to the company's reputation ... Explore everything the blog has to offer at ... through all the information concerning the Affordable Care ... blog aims to inform the public about a ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... -- An experimental antibody drug could prove effective at ... side effects with cholesterol-lowering statin medications. That,s the ... American Heart Association annual meeting in Chicago. The ... the most widely used alternative to statins, Zetia, said ...
(Date:11/18/2014)... News) -- Women who started smoking at a young ... menstrual pain, a new study suggests. About 29 ... has been suspected as a risk factor for severe ... of the new study said. The researchers analyzed ... study of women,s health in Australia. About 14 percent ...
Breaking Medicine News(10 mins):Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2
... announced their plans to use a protein that has been ... ice creams using genetically// modified technology. ,The parent ... them to develop ice creams that are of low-calorie, and ... technology to make newer versions of their best selling products ...
... Institute for Health and Clinical Excellence (Nice) has said that ... they can be well equipped to avoid unnecessary treatment at ... in consultant units appeared to be safer than midwife births ... mid-wife centers than at homes. It added that a birth ...
... join hands against HIV/AIDS and are set to discuss the ... ,Alarmed by the rising numbers of HIV/AIDS cases in the ... across party lines are to participate in a conference here ... the assembly speaker, said that over 300 legislators including 243 ...
... of 16-year-old Robina Bibi in Pakistan's North West Frontier Province ... poverty forced them to look for buyers. ,It ... 40, and her husband Izat Gul, 43 - could think ... from hepatitis C. ,They struck a deal with ...
... lead a healthy life as they have access to good ... of poor families this rosy scenario does not exist. Public ... what works to help all children do the best they ... of kids. Hence the Health Council of Canada decided to ...
... the final approval from USFDA to market its Abbreviated New ... ,The company informed the Bombay Stock Exchange that ... mg, 10 mg, 20 mg and 40 mg. , ... Accupril and its market is estimated to be about 300 ...
Cached Medicine News:Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2Health News:Bihar Legislators Join Hands to Fight Against AIDS 2Health News:Impoverished Parents sell their Daughter to Treat their Ailing Kids 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: